» Articles » PMID: 25114142

Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin Against Biofilms from Staphylococcus Aureus Clinical Isolates

Overview
Specialty Pharmacology
Date 2014 Aug 13
PMID 25114142
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Biofilm-related infections remain a scourge. In an in vitro model of biofilms using Staphylococcus aureus reference strains, delafloxacin and daptomycin were found to be the most active among the antibiotics from 8 different pharmacological classes (J. Bauer, W. Siala, P. M. Tulkens, and F. Van Bambeke, Antimicrob. Agents Chemother. 57:2726-2737, 2013, doi:10.1128/AAC.00181-13). In this study, we compared delafloxacin to daptomycin and vancomycin using biofilms produced by 7 clinical strains (S. aureus epidemic clones CC5 and CC8) in order to rationalize the differences observed between the antibiotics and strains. The effects of the antibiotics on bacterial viability (resazurin reduction assay) and biomass (crystal violet staining) were measured and correlated with the proportion of polysaccharides in the matrix, the local microenvironmental pH (micro-pH), and the antibiotic penetration in the biofilm. At clinically meaningful concentrations, delafloxacin, daptomycin, and vancomycin caused a ≥25% reduction in viability against the biofilms formed by 5, 4, and 3 strains, respectively. The antibiotic penetration within the biofilms ranged from 0.6 to 52% for delafloxacin, 0.2 to 10% for daptomycin, and 0.2 to 1% for vancomycin; for delafloxacin, this was inversely related to the polysaccharide proportion in the matrix. Six biofilms were acidic, explaining the high potency of delafloxacin (lower MICs at acidic pH). Norspermidine and norspermine (disassembling the biofilm matrix) drastically increased delafloxacin potency and efficacy (50% reduction in viability for 6 biofilms at clinically meaningful concentrations) in direct correlation with its increased penetration within the biofilm, while they only modestly improved daptomycin efficacy (50% reduction in viability for 2 biofilms) and penetration, and they showed marginal effects with vancomycin. Delafloxacin potency and efficacy against biofilms are benefited by its penetration into the matrix and the local acidic micro-pH.

Citing Articles

A prospective study to evaluate high dose daptomycin pharmacokinetics and pharmacodynamics in spp. infective endocarditis.

De Gregori S, De Silvestri A, Capone M, Monzillo V, Giordani P, Bruno R Ther Adv Infect Dis. 2025; 12():20499361241296232.

PMID: 39791119 PMC: 11713942. DOI: 10.1177/20499361241296232.


Fluoroquinolones and Biofilm: A Narrative Review.

Geremia N, Giovagnorio F, Colpani A, De Vito A, Botan A, Stroffolini G Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770514 PMC: 11679785. DOI: 10.3390/ph17121673.


Antibiofilm approaches as a new paradigm for treating infections.

Reffuveille F, Dghoughi Y, Colin M, Torres M, de la Fuente-Nunez C Prog Biomed Eng (Bristol). 2024; 6(2).

PMID: 39506977 PMC: 11540418. DOI: 10.1088/2516-1091/ad1cd6.


Biofilm-mediated antibiotic tolerance in from spinal cord stimulation device-related infections.

Sivori F, Cavallo I, Truglio M, Pelagalli L, Mariani V, Fabrizio G Microbiol Spectr. 2024; :e0168324.

PMID: 39470274 PMC: 11619394. DOI: 10.1128/spectrum.01683-24.


Agar and agarose used for Staphylococcus aureus biofilm cultivation impact fluoroquinolone tolerance.

Power A, Mok W J Appl Microbiol. 2024; 135(8).

PMID: 39066496 PMC: 11301810. DOI: 10.1093/jambio/lxae191.


References
1.
Croes S, Deurenberg R, Boumans M, Beisser P, Neef C, Stobberingh E . Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage. BMC Microbiol. 2009; 9:229. PMC: 2774858. DOI: 10.1186/1471-2180-9-229. View

2.
Seaton R, Malizos K, Viale P, Gargalianos-Kakolyris P, Santantonio T, Petrelli E . Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database. J Antimicrob Chemother. 2013; 68(7):1642-9. PMC: 3682689. DOI: 10.1093/jac/dkt067. View

3.
Gil C, Solano C, Burgui S, Latasa C, Garcia B, Toledo-Arana A . Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection. Infect Immun. 2013; 82(3):1017-29. PMC: 3957983. DOI: 10.1128/IAI.01419-13. View

4.
Mataraci E, Dosler S . In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2012; 56(12):6366-71. PMC: 3497160. DOI: 10.1128/AAC.01180-12. View

5.
Hunter R, Beveridge T . Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2005; 71(5):2501-10. PMC: 1087576. DOI: 10.1128/AEM.71.5.2501-2510.2005. View